• ICR scientists find new target protein for cancer pharmaceutical-technology
    December 11, 2017
    Scientists at the Institute of Cancer Research (ICR) in the UK have found that inhibition of the cyclin G associated kinase (GAK) protein has the potential to allow treatment of different types of cancer.
  • ICR scientists find new target protein for cancer pharmaceutical-technology
    December 11, 2017
    Scientists at the Institute of Cancer Research (ICR) in the UK have found that inhibition of the cyclin G associated kinase (GAK) protein has the potential to allow treatment of different types of cancer.
PharmaSources Customer Service